A FRET sensor for non-invasive imaging of amyloid formation in vivo.

Misfolding and aggregation of amyloidogenic polypeptides lie at the root of many neurodegenerative diseases. Whilst protein aggregation can be readily studied in vitro by established biophysical techniques, direct observation of the nature and kinetics of aggregation processes taking place in vivo is much more challenging. We describe here, however, a Förster resonance energy transfer sensor that permits the aggregation kinetics of amyloidogenic proteins to be quantified in living systems by exploiting our observation that amyloid assemblies can act as energy acceptors for variants of fluorescent proteins. The observed lifetime reduction can be attributed to fluorescence energy transfer to intrinsic energy states associated with the growing amyloid species. Indeed, for a-synuclein, a protein whose aggregation is linked to Parkinson's disease, we have used this sensor to follow the kinetics of the self-association reactions taking place in vitro and in vivo and to reveal the nature of the ensuing aggregated species. Experiments were conducted in vitro, in cells in culture and in living Caenorhabditis elegans. For the latter the readout correlates directly with the appearance of a toxic phenotype. The ability to measure the appearance and development of pathogenic amyloid species in a living animal and the ability to relate such data to similar processes observed in vitro provides a powerful new tool in the study of the pathology of the family of misfolding disorders. Our study confirms the importance of the molecular environment in which aggregation reactions take place, highlighting similarities as well as differences between the processes occurring in vitro and in vivo, and their significance for defining the molecular physiology of the diseases with which they are associated.

[1]  D. Selkoe,et al.  Cell biology of protein misfolding: The examples of Alzheimer's and Parkinson's diseases , 2004, Nature Cell Biology.

[2]  C. Dobson,et al.  Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases , 2002, Nature.

[3]  D. Holtzman,et al.  Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer’s disease , 2008, Nature.

[4]  V. Subramaniam,et al.  Dependence of α-synuclein aggregate morphology on solution conditions , 2002 .

[5]  C. Dobson,et al.  Towards multiparametric fluorescent imaging of amyloid formation: studies of a YFP model of alpha-synuclein aggregation. , 2010, Journal of molecular biology.

[6]  E. Rodriguez-Boulan,et al.  Efficient Electroporation of DNA and Protein into Confluent and Differentiated Epithelial Cells in Culture , 2007, Traffic.

[7]  S. Hell,et al.  Direct observation of the nanoscale dynamics of membrane lipids in a living cell , 2009, Nature.

[8]  C. Dobson,et al.  Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution , 2003, Journal of Molecular Medicine.

[9]  Ehud Gazit,et al.  A possible role for π‐stacking in the self‐assembly of amyloid fibrils , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  J. Pines,et al.  A quantitative protocol for dynamic measurements of protein interactions by Förster resonance energy transfer-sensitized fluorescence emission , 2009, Journal of The Royal Society Interface.

[11]  R. Crowther,et al.  α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies , 1998 .

[12]  Clemens F Kaminski,et al.  Quantitative imaging of human red blood cells infected with Plasmodium falciparum. , 2010, Biophysical journal.

[13]  Fabrizio Chiti,et al.  A causative link between the structure of aberrant protein oligomers and their toxicity. , 2010, Nature chemical biology.

[14]  C. Kaminski,et al.  Fluorescence intensity and lifetime imaging of free and micellar-encapsulated doxorubicin in living cells. , 2008, Nanomedicine : nanotechnology, biology, and medicine.

[15]  J. Lippincott-Schwartz,et al.  Imaging Intracellular Fluorescent Proteins at Nanometer Resolution , 2006, Science.

[16]  Brian J Bacskai,et al.  Four-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-β ligand in transgenic mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Takeharu Nagai,et al.  Shift anticipated in DNA microarray market , 2002, Nature Biotechnology.

[18]  Songsong Cao,et al.  Hypothesis-based RNAi screening identifies neuroprotective genes in a Parkinson's disease model , 2008, Proceedings of the National Academy of Sciences.

[19]  C. Kaminski,et al.  Rotaviruses Associate with Cellular Lipid Droplet Components To Replicate in Viroplasms, and Compounds Disrupting or Blocking Lipid Droplets Inhibit Viroplasm Formation and Viral Replication , 2010, Journal of Virology.

[20]  C. Kaminski,et al.  Catalytic and chaperone-like functions in an intrinsically disordered protein associated with desiccation tolerance , 2010, Proceedings of the National Academy of Sciences.

[21]  R. Breitling,et al.  C. elegans Model Identifies Genetic Modifiers of α-Synuclein Inclusion Formation During Aging , 2008, PLoS genetics.

[22]  D. Sulzer,et al.  Interplay between Cytosolic Dopamine, Calcium, and α-Synuclein Causes Selective Death of Substantia Nigra Neurons , 2009, Neuron.

[23]  Richard I. Morimoto,et al.  The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[24]  J. Trojanowski,et al.  A comparison of amyloid fibrillogenesis using the novel fluorescent compound K114 , 2003, Journal of neurochemistry.

[25]  P. Lansbury,et al.  Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Roberto Cingolani,et al.  Charge transport and intrinsic fluorescence in amyloid-like fibrils , 2007, Proceedings of the National Academy of Sciences.

[27]  Ehud Cohen,et al.  Opposing Activities Protect Against Age-Onset Proteotoxicity , 2006, Science.

[28]  P. Neudecker,et al.  Structural properties and dynamic behavior of nonfibrillar oligomers formed by PrP(106-126). , 2010, Journal of the American Chemical Society.

[29]  C. Dobson Protein folding and misfolding , 2003, Nature.

[30]  L. Runnels,et al.  Theory and application of fluorescence homotransfer to melittin oligomerization. , 1995, Biophysical journal.

[31]  R. Morimoto,et al.  Destabilizing Protein Polymorphisms in the Genetic Background Direct Phenotypic Expression of Mutant SOD1 Toxicity , 2009, PLoS genetics.

[32]  T. Dawson,et al.  Molecular Pathways of Neurodegeneration in Parkinson's Disease , 2003, Science.

[33]  P. Lansbury,et al.  Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson's disease. , 2003, Biochemistry.

[34]  A. Jeyasekharan,et al.  A white light confocal microscope for spectrally resolved multidimensional imaging , 2007, Journal of microscopy.

[35]  Alejandro Chavez,et al.  Genome-wide RNA interference screen identifies previously undescribed regulators of polyglutamine aggregation. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[36]  P. Lansbury,et al.  Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. , 2003, Annual review of neuroscience.

[37]  Clemens F. Kaminski,et al.  Biophotonic techniques for the study of malaria-infected red blood cells , 2010, Medical & Biological Engineering & Computing.

[38]  V. Subramaniam,et al.  Impact of the acidic C-terminal region comprising amino acids 109-140 on alpha-synuclein aggregation in vitro. , 2004, Biochemistry.

[39]  R. Wetzel,et al.  Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity. , 2001, Journal of molecular biology.

[40]  V. Agrawal,et al.  A novel UV laser-induced visible blue radiation from protein crystals and aggregates: scattering artifacts or fluorescence transitions of peptide electrons delocalized through hydrogen bonding? , 2004, Archives of biochemistry and biophysics.

[41]  Shubo Han,et al.  The Flavonoid Baicalein Inhibits Fibrillation of α-Synuclein and Disaggregates Existing Fibrils* , 2004, Journal of Biological Chemistry.

[42]  M. Alpers Published online: , 2001 .

[43]  Uli Lemmer,et al.  AGGREGATE FLUORESCENCE IN CONJUGATED POLYMERS , 1995 .

[44]  D. Otzen,et al.  Unique identification of supramolecular structures in amyloid fibrils by solid-state NMR spectroscopy. , 2009, Angewandte Chemie.

[45]  S Schlachter,et al.  A method to unmix multiple fluorophores in microscopy images with minimal a priori information. , 2009, Optics express.

[46]  A. Hill,et al.  Dopamine and the dopamine oxidation product 5,6-dihydroxylindole promote distinct on-pathway and off-pathway aggregation of alpha-synuclein in a pH-dependent manner. , 2009, Journal of molecular biology.

[47]  Brian J Bacskai,et al.  Fluorescence resonance energy transfer determinations using multiphoton fluorescence lifetime imaging microscopy to characterize amyloid-beta plaques. , 2003, Journal of biomedical optics.

[48]  Clemens F. Kaminski,et al.  A spectroscopic study of the self-association and inter-molecular aggregation behaviour of pH-responsive poly(l-lysine iso-phthalamide) , 2006 .

[49]  Clemens F. Kaminski,et al.  FRET Imaging of Hemoglobin Concentration in Plasmodium falciparum-Infected Red Cells , 2008, PloS one.

[50]  H. Heise Solid‐State NMR Spectroscopy of Amyloid Proteins , 2008, Chembiochem : a European journal of chemical biology.

[51]  Tianhong Pan,et al.  The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease. , 2008, Brain : a journal of neurology.

[52]  Makoto Hashimoto,et al.  β-Synuclein Inhibits α-Synuclein Aggregation A Possible Role as an Anti-Parkinsonian Factor , 2001, Neuron.

[53]  Peter T. Lansbury,et al.  Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy , 2004, Science.